Category: Uncategorized
Field study for improvement in WHO’s IIEF (The International Index of erectile function) parameters with C23C tablets.
Brief Summary :
The purpose of the multicentric field study was to see the improvement in IIEF parameters with C23C tablets.
Study Design :
We had selected 3 centers namely Jaipur, Lucknow, and Mumbai. The study was done by Physicians / General practitioners on 20 patients.
Method :
Once the doctor concluded through clinical experience and interactions with patients having symptoms of erectile dysfunction, the doctor filled up the IIEF form as prescribed by WHO, this was considered Day 0. If the scores were lower the limit set by WHO the patient had an erectile dysfunction. Other points that were added and in patient information included comorbidities including diabetes, hypertension, anxiety and obesity (calculation based on height and weight).
The patients were advised to be on C23C tablets for a period of 30 days. Post day 30 they were visit the doctor for reassessment of IIEF scores.
Results :
There were no adverse observations reported in any of the patients. Average of IIEF scores and number of attempts per month on day 0 and day 30 mentioned in the chart. There is a remarkable improvement in the scores on day 30 in all 5 functional domains of IIEF and number of attempts per month.
For the use of registered medical practitioner only.
Disclaimer : This is not intended to promote self-medication. Always consult your doctor before taking any medication and / or if signs and symptoms persist.
Field study for improvement in semen quality parameters with C23C tablets
Brief Summary :
The purpose of the multicentric field study was to see the improvement in semen quality in oligospermic patients with C23C tablets.
Study Design :
We had selected 3 centers namely Chapra, Tumkur, and Ahmedabad. The study was done by Gynecologists on 10 patients.
Method :
Once the doctor concluded the male patient to have low sperm count / motility / morphology through a lab report, the patient was advised to be on C23C tablets for period of 90 days. The initial report was considered to be day 0 report. The last report post day 30 was considered to be the final report.
Results :
There were no adverse observations reported in any of the patients. Percentage increase, before and after treatment, in sperm count, sperm motility, and sperm morphology mentioned in the chart. There is significant increase in all 3 semen quality parameters with C23C tablets.
For the use of registered medical practitioner only.
Disclaimer : This is not intended to promote self-medication. Always consult your doctor before taking any medication and / or if signs and symptoms persist.
FAQs on Erectile Dysfunction
What is erectile dysfunction?
“Erectile dysfunction (ED) is the failure to achieve erection, ejaculation, or both.”
Evaluation of erectile dysfunction can be through
- International Index of Erectile Function (IIEF)
What is International index of erectile function?
- It is a comprehensive questionnaire approved by the WHO for assessment of
- Erectile function
- Orgasmic function
- Sexual desire
- Intercourse satisfaction
- Overall satisfaction
Who needs to be assessed?
- This assessment is specifically for the male population
- Age > 50
- Comorbidities like diabetes, hypertension for more than 5 years
- Those who are unable to get an/or sustain erection
Common causes of low IIEF score:
- Age
- Stress
- Co-morbidity including diabetes, hypertension and medications there of
- Generally lower physical activity
- Overweight conditions
- Smoking
- Tobacco
- Habituated alcohol consumption more than 3 times a week
What is C23C?
- Brand name meaning – “See 23 Chromosomes”
- Fertilization occurs when 23 female chromosomes unite with 23 male chromosomes
Is it Ayurvedic?
- Yes. C23C is an ayurvedic formulation, drawing on the wisdom from ancient text bhavprakasha
Are there any trials on done with C23C?
- Yes C23C is being currently assessed / evaluated at multiple centers for
- Treatment of male erectile dysfunction
- Improvement in IIEF score is the primary end point of the trial
- A sample IIEF score is available for self-assessment Patients scoring low in the IIEF score on day 0 are given treatment of C23C for 1 month, to check on the improvement of score.
- Improvement in IIEF score is the primary end point of the trial
For the use of registered medical practitioner only.
Disclaimer: This is not intended to promote self-medication. Always consult your doctor before taking any medication and / or if signs and symptoms persist.
FAQs on Infertility
What is infertility?
WHO-defines
“Infertility is a disease of the male or female reproductive system defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse.”
The causes of infertility can be due to:
A – Issues related to the woman partner – 1/3 chance
B – Issues related to the male partner – 1/3 chance
C – No cause – 1/3 chance
One of the ways to diagnose Issues related to male partner can be through
- Semen analysis (where following parameters are usually checked)
- Count / ml – greater the count better the probability of conceiving
- Motility – greater number of motile sperms better chance of conceiving
- Morphology – greater number of normal sperms better chances of conceiving
- Vitality (alive sperms) – greater number sperms alive better chances of conceiving
Why is male infertility on the rise?
- Late age for family planning
- With lifestyle changes, co-morbidities like diabetes and hypertension, medications thereof are on the rise even in young adults there by leading to not only lowering of testosterone the male hormone for vigor and performance but also adversely affecting semen quality
- Stress
- Lower physical exercise leading to overweight
What is C23C?
- Brand name meaning – “See 23 Chromosomes”
- Fertilization occurs when 23 female chromosomes unite with 23 male chromosomes
Is it Ayurvedic?
- Yes. C23C is an ayurvedic formulation, drawing on the wisdom from ancient text bhavprakasha
Are there any trials on done with C23C?
- Yes C23C is being currently assessed / evaluated at multiple centers for
- Improvement of Semen Quality Patients with oligospermia i.e. patients either with sperm count < 15 million / ml but greater than 1 m, reduced motility, morphology, vitality or a combination of the four, are given C23C for 3 months They are given medication for 3 months,
- Initials results show
- Improvement in quantity of sperms / ml
- Improvement in motility
- Improvement in morphology
For the use of registered medical practitioner only.
Disclaimer: This is not intended to promote self-medication. Always consult your doctor before taking any medication and / or if signs and symptoms persist.